Catalyst Wire Dossier Catalyst Wire Dossier

Tiotropium inhalation solution (Respimat)

tiotropium · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Tiotropium inhalation solution (Respimat), covering 2013-11-01 to 2014-11-18. Get the full timeline:

Most recent: Clinical Trial Update: A Collection of Vital Status and Pulmonary Medication Usage Data for Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Withdrew Prematurely From Tiotropium Inhalation Solution Delivered by the Respimat Inhaler

See pricing